Palliative Chemotherapy is Well Tolerated in a Patient With Metastatic Colorectal Cancer Due to Bloom Syndrome With a Novel BLM Mutation
Dose modified multiagent chemotherapy was well tolerated in an adolescent patient with Bloom Syndrome and metastatic colorectal cancer.
Authors
- Katherine Anderson (ORCID: https://orcid.org/0000-0001-6102-838X)
- Thomas Lahiri (ORCID: https://orcid.org/0000-0001-8374-4918)
- Amelia Sybenga (ORCID: https://orcid.org/0000-0001-9231-6800)
- Timothy Higgins
- Jessica L. Heath (ORCID: https://orcid.org/0000-0003-1771-2242)
- Juleysi Delgado Baca
Institutions
- University of Vermont (US)
- University of Vermont Children’s Hospital (US)
Publication Details
- Journal
- Journal of Pediatric Hematology/Oncology
- Published
- 2025-08-20
- DOI
- https://doi.org/10.1097/mph.0000000000003108
- Primary Topic
- DNA Repair Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00